Restoring ammonia capture near liver veins may preserve muscle and brain function and extend life
Restoring glutamine synthetase activity in 80% of mapped liver cells near veins could reduce ammonia peaks and preserve muscle and brain function. Normalized ammonia with unchanged functional decline and survival would reject the proposed route to longer life.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 5 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Enzyme
Glutamine synthetase
An enzyme involved in binding ammonia through glutamine formation
Where this hypothesis actsIn 80% of the initially mapped perivenous hepatocytes after ordinary food intake and physical activity
Hypotheses on this target 2
Inhibition
Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation
What is proposed
Restore glutamine synthetase activity
With whatControlled genetic model
HowInducible modification of Glul, with spatial marking of the perivenous population and verification of intervention selectivity
Possible result
Possible reduction in ammonia peaks, preservation of muscle strength and cognition, and longer remaining lifespan
From the recordПредлагаемый набор состоит только из перивенозных гепатоцитов, содержащих глутаминсинтетазу, с восстановлением её активности в 80% клеток этой исходно картированной популяции.
Metabolite or ion
Ammonia
A nitrogen-containing molecule whose load can be reduced through chemical binding
Where this hypothesis actsResidual ammonia load and systemic peaks after combined ordinary food intake and physical activity
Hypotheses on this target 1
Supplementation
Accelerated excretion
Composition restoration
What is proposed
Reduce ammonia peaks by increasing its chemical binding
With whatNot stated in the record
HowRestore glutamine synthetase activity in 80% of mapped perivenous hepatocytes; reproduce the original ammonia profile to test mediation
Possible result
Possible preservation of muscle strength and cognitive function and longer remaining lifespan
From the recordПовторное выключение глутаминсинтетазы в скорректированных клетках либо восстановление исходного аммиачного профиля отменяет удалённую пользу.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A small group of liver cells might connect the handling of everyday meals and physical activity to declining strength, thinking and survival. The unexpected move is to propose restoring one chemical reaction in 80% of that group while leaving other liver cells without direct correction. This is a hypothesis generated by the pipeline, not a measured result; both the claimed benefits and the proposed coverage requirement remain to be tested.
- Insufficient ammonia capture by the small liver cell population is proposed to leave higher ammonia peaks after meals and physical activity.
- Restoring glutamine synthetase activity in 80% of the initially mapped population is proposed to increase incorporation of ammonia into glutamine.
- The increased capture is predicted to reduce those ammonia peaks without direct correction of other liver cells.
- Lower ammonia peaks are predicted to preserve muscle strength and thinking and memory.
- The same correction is predicted to extend remaining life.
- Switching the restored enzyme off again, or recreating the original ammonia pattern over time, is predicted to remove the benefits outside the liver.
A small cleanup crew at the end of a busy kitchen's waste line might be enough to prevent waste from backing up during meal rushes. Restoring most of that crew could help even if the rest of the kitchen stays unchanged.
Where the picture breaks: Ammonia is chemically transformed and handled by several tissues, rather than collected at one final outlet. The picture cannot establish how many cells are sufficient or whether reducing ammonia preserves strength, thinking or lifespan.
- Master questionstep 01 of 04
Processes involved in aging may reinforce one another, so correcting a shared cause could benefit several body systems at once.
Rests on: The goal takes the possibility of a shared, correctable cause as the basis for seeking interventions that extend life.
AssumptionThe starting premise assumes that some mutually reinforcing aging processes have a shared cause whose correction can improve several systems and extend life. The supplied goal does not establish that such a cause exists.
- Goal pillarstep 02 of 04
The desired output is a set of life-extension ideas that act through distinct causes.
Rests on: The master question explicitly requests ideas for interventions that could benefit several systems by acting on a shared cause.
Stated in the chain - Gap questionstep 03 of 04
Specific tissues, cell groups or bounded spaces within the body become candidate locations for a shared cause, with targeted correction and subsequent reversal used to distinguish their effects on several systems and lifespan.
Rests on: The preceding goal calls for causally distinct ideas, but does not specify where their causes reside or how the alternatives should be separated.
AssumptionThe search assumes that a useful shared cause can be located in a defined biological compartment and examined through targeted correction followed by reversal of the proposed connecting process. This is an added framework for the search, not an established property of the candidates.
- Hypothesisstep 04 of 04
Restoring glutamine synthetase, an enzyme that incorporates ammonia into the amino acid glutamine, in 80% of the initially mapped perivenous hepatocytes, meaning liver cells surrounding central veins, is proposed to reduce ammonia peaks after meals and physical activity. Ammonia is a nitrogen-containing substance whose accumulation can be harmful. The predicted consequences are preserved muscle strength, thinking and memory, and longer remaining life, without directly correcting other liver cells. The proposal predicts that 40% coverage is insufficient and 100% provides no additional benefit over 80%; these are experimental comparisons, not established biological thresholds.S2
Rests on: The preceding stage supplies the search for a localized cause and a reversible test. S2, a 2021 review in Biological Chemistry, describes a small liver cell population around veins whose glutamine synthetase helps maintain low ammonia levels; it does not establish the restoration strategy, coverage requirements, benefits after ordinary activity or effects on lifespan.
Supported by literature
What is carried, and what is not. Screened sources speak to three parts of the proposed sequence, with different limits: S2 in Biological Chemistry (2021) links this liver cell population to ammonia control but does not test restoration; S3 in Proceedings of the National Academy of Sciences of the United States of America (2019) links impaired glutamine production to raised ammonia in mice lacking a particular transport protein, rather than testing the proposed correction; and S5 in Endocrinology (2021) reports lower ammonia alongside increased survival after a different intervention in male mice with an inherited ammonia-disposal disorder, without establishing ammonia reduction as the cause of survival improvement. None establishes the sequence from selective restoration through ordinary meal and activity responses to preserved muscle and brain function and longer life, or validates the 40%, 80% and 100% comparisons.S2S3S5
Where the reasoning is carried by something unstated · 2
- Master question. The starting premise assumes that some mutually reinforcing aging processes have a shared cause whose correction can improve several systems and extend life. The supplied goal does not establish that such a cause exists.
- Gap question. The search assumes that a useful shared cause can be located in a defined biological compartment and examined through targeted correction followed by reversal of the proposed connecting process. This is an added framework for the search, not an established property of the candidates.
How a result here could mislead · 3
- Benefits could be credited to the selected liver cells even if the intervention also changes the brain, muscles or other liver regions. Changes in one of the rival mechanisms could likewise be mistaken for evidence that ammonia capture alone was sufficient. What closes it: The proposed selectivity checks must verify restored enzyme activity in the intended cells and its absence elsewhere. The test must also verify the predicted lack of change in apolipoprotein B, a protein involved in transporting fats in blood, specifically its production accuracy; hormone pulses, meaning repeated rises and falls in hormone levels; and thymic antigen presentation, meaning the display of the body's own molecular fragments to developing immune cells in the thymus.
- Loss of benefit after recreating the original ammonia pattern could be attributed to ammonia even if the procedure also changes glutamine or the body's balance of acidity and alkalinity. Conversely, failure to lose the benefit would be ambiguous if the original ammonia pattern was not actually restored. What closes it: The reversal must verify the ammonia pattern over time and separately measure glutamine and acid-base balance, meaning the balance of acidity and alkalinity. Changes in these accompanying quantities must be controlled or otherwise separated before loss of benefit can be assigned specifically to ammonia.
- Failure at 40% and similar outcomes at 80% and 100% could be read as proof that 80% is the minimum sufficient coverage, even if the groups differ in restored activity per cell or the experiment cannot distinguish meaningful outcome differences. Those three coverage levels also leave intermediate coverage untested. What closes it: Coverage must use the initially mapped population as its denominator and be accompanied by measurements of restored activity and ammonia incorporation into glutamine. The combined meal and activity challenge, the functional success criterion and the allowed difference for declaring 80% and 100% equivalent must be fixed before testing; no numerical criteria are supplied. These comparisons can establish sufficiency among the tested levels, but cannot locate an exact minimum between 40% and 80%.
What would make this wrong. The proposal fails as a shared life-extension target if verified selective restoration normalizes ammonia, but muscle and brain function and survival continue along their original trajectories. Its claim that ammonia carries the distant benefits would also be contradicted if those benefits persisted after the original ammonia pattern was successfully recreated under conditions that separated accompanying glutamine and acid-base changes.
What it would change. If selective restoration preserved muscle and brain function, extended remaining life and lost its benefits when the ammonia pattern was restored, a small liver cell population would become a supported candidate for the master question's shared causal target. Work on that question would then have a reason to compare narrowly targeted ammonia capture with broader interventions, rather than assuming that several tissues require direct correction. The supplied endpoint does not specify the species, starting age, duration or detailed outcome criteria, so even a successful test would leave its relevance to human aging and its generality across settings unestablished.
Sources read · 9
Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis. · JHEP reports : innovation in hepatology · 2021
“Zone 3 hepatocytes are located around the central veins and are responsible for glycolysis, lipogenesis, and biotransformation reactions.”
Does not settle: This source text does not test glutamine synthetase restoration, ammonia peaks after feeding or exercise, muscle strength, cognition, lifespan, or the proposed 40%, 80%, and 100% coverage thresholds.
Glutamine synthetase as a central element in hepatic glutamine and ammonia metabolism: novel aspects. · Biological chemistry · 2021
“Glutamine synthetase (GS) in the liver is expressed in a small perivenous, highly specialized hepatocyte population and is essential for the maintenance of low, non-toxic ammonia levels in the organism.”
Does not settle: Источник не проверяет восстановление активности глутаминсинтетазы в 40%, 80% или 100% перивенозных гепатоцитов, аммиачные пики после пищевых и двигательных нагрузок, мышечную силу, когнитивные функции, продолжительность жизни или достаточность отсутствия коррекции других гепатоцитов.
Taurine transporter (TauT) deficiency impairs ammonia detoxification in mouse liver. · Proceedings of the National Academy of Sciences of the United States of America · 2019
“It is concluded that TauT deficiency triggers hyperammonemia through impaired hepatic glutamine synthesis due to an impaired ammonia transport via RhBG at 3 months and a tyrosine nitration-dependent inactivation of GS in 12-month-old TauT KO mice.”
Does not settle: Источник изучает мышей с дефицитом транспортера таурина. Он не проверяет восстановление глутаминсинтетазы в перивенозных клетках, охват 40%, 80% или 100%, пищевые и двигательные нагрузки, мышечную силу, когнитивные функции или продолжительность жизни.
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy. · Drugs · 2019
“Transformations of the constituent amino acids of LOLA either via the hepatic urea cycle into urea per se or into glutamine via glutamine synthetase expressed by perivenous hepatocytes, brain, and skeletal muscle afford multiple pathways whereby ammonia is readily removed.”
Does not settle: Источник не проверяет избирательное восстановление глутаминсинтетазы в перивенозных гепатоцитах, охват 40%, 80% или 100%, аммиачные пики после обычных нагрузок, сохранение когнитивных функций или мышечной силы при такой коррекции, а также оставшуюся продолжительность жизни.
Glucagon Receptor Inhibition Reduces Hyperammonemia and Lethality in Male Mice with Urea Cycle Disorder. · Endocrinology · 2021
“The gene expression changes favor ammonia consumption and were accompanied by increased circulating glutamine levels and diminished hyperammonemia. Otcspf-ash mice treated with the glucagon receptor-blocking antibody gained lean and body mass and had increased survival.”
Does not settle: Остаются открытыми восстановление активности глутаминсинтетазы именно в перивенозных гепатоцитах, охват 40%, 80% или 100% этой популяции, последствия обычных пищевых и двигательных нагрузок, мышечная сила, когнитивные функции и переносимость результата на людей.
Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency. · Virchows Archiv : an international journal of pathology · 2018
“Our data indicate that the proportion of about 20-30% of hepatocytes expressing the functional OTC protein is not sufficient to maintain metabolic stability.”
Does not settle: Источник касается дефицита орнитинтранскарбамилазы у двух женщин и не устанавливает эффект восстановления глутаминсинтетазы в перивенозных гепатоцитах. Он не оценивает охват 40%, 80% или 100%, аммиачные пики после нагрузок, мышечную силу, когнитивные функции или продолжительность жизни.
Ammonia modifies enteric neuromuscular transmission through glial γ-aminobutyric acid signaling. · American journal of physiology. Gastrointestinal and liver physiology · 2017
“Inhibition of glutamine synthetase and the deletion of glial connexin-43 channels in hGFAP :: Cre ER T2+/− /connexin43 f/f mice potentiated the effects of ammonia on neuromuscular transmission.”
Does not settle: Источник исследует глиальные клетки кишечника и нервно-мышечную передачу. Он не устанавливает роль перивенозных гепатоцитов, охват восстановления глутаминсинтетазы на 40%, 80% или 100%, аммиачные пики после нагрузки, мышечную силу, когнитивные функции или продолжительность жизни.
Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis. · iMeta · 2026
“Microbial‐community and host metabolic modeling further suggested that these microbial metabolic shifts may influence host energy metabolism and redox balance across the liver, brain, and skeletal muscle.”
Does not settle: Источник не изучает перивенозные гепатоциты, глутаминсинтетазу, восстановление её активности, охват 40%, 80% или 100%, аммиачные пики после нагрузок, мышечную силу, когнитивные функции или продолжительность жизни.
Hyperammonemia Physiology and Management: A Nephrology-Centered Review. · Advances in kidney disease and health · 2026
“This review highlights the physiological roles of the intestine, liver, skeletal muscle, brain, and kidneys in ammonia homeostasis, with emphasis on acid-base and potassium regulation.”
Does not settle: Обзорный абстракт не устанавливает роль перивенозных гепатоцитов с глутаминсинтетазой, не сравнивает охват 40%, 80% и 100%, не измеряет аммиачные пики после нагрузок и не сообщает о мышечной силе, когнитивных функциях или продолжительности жизни.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
Which tissue targets improve multiple systems and lifespan through a shared link rather than separate organ effects?
Original wording · exactly as the pipeline generated it
Какие ткани, клеточные популяции или компартменты содержат общие причинные звенья для самостоятельных идей «серебряных пуль», если адресная коррекция и обратное выключение посредника должны отличить их от конкурирующих мишеней по функциям нескольких систем и продолжительности жизни?
What this question is asking
The question asks where in the body a change could improve several bodily functions and extend life through one shared biological link. It seeks particular tissues, groups of cells, or distinct biological locations where targeted correction produces those benefits, and asks whether subsequently disabling the proposed mediator removes them. The comparison is with competing targets, including targets whose effects act separately on individual organs, using sustained function and lifespan over a common observation period. The question assumes that existing mapping and local interventions identify candidates but have not established a set of shared causal targets; the supplied sources establish only parts of that assumption.
- Tissue, cell population, and biological compartment
- A tissue is an organized part of the body made from cells; a cell population is a group of cells considered together. A compartment is a distinct biological location, such as a region within a cell or a body fluid, and the question asks where the proposed shared cause resides.
- Target and targeted correction
- A target is a biological component or process selected for change. Targeted correction means changing that component in the relevant location; calling it a correction does not establish that it produces a benefit.
- Shared causal target
- A component whose alteration causes effects in several body systems through a common link. A feature found in several tissues is only a candidate until its causal role is established.
- Mediator and mediator dependence
- A mediator is an intermediate part of the chain connecting an intervention to an outcome. Dependence means that the outcome requires that intermediate link; the question asks whether benefits are lost when the link is subsequently disabled.
- Multisystem function
- How well several body systems perform their jobs. Changes in several measured substances are not themselves evidence that several systems function better.
- Lifespan and healthspan
- Lifespan is how long an organism lives. Healthspan concerns time spent in good health or with preserved function, with the exact definition depending on how a study measures it.
- RL-1 and RL-2
- Labels used by the pipeline for levels of mapping and local intervention evidence. Their expansions and criteria are not supplied, so their evidential meaning cannot be established from this input.
- Gene activity
- The use of genetic instructions to make cellular products. S1 concerns regulation of this activity, while S7 measures the abundance of molecular instructions for particular proteins.
- Inflammation
- A set of immune responses involved in responding to damage or threats. Persistent inflammation is one of the processes discussed in the supplied accounts of fasting and communication between fat tissue and the brain.
- Caenorhabditis elegans and hypodermis
- Caenorhabditis elegans is the worm species studied in S2. Its hypodermis is an outer body tissue, compared with muscle in that source's imaging procedures.
- Mitophagy
- The process by which cells remove mitochondria, internal structures involved in energy production. S3 discusses its relationship with stress across ages and cell types rather than establishing a shared life-extending target.
- Ergothioneine
- A dietary antioxidant, meaning a substance associated with limiting certain damaging chemical reactions. S4 reports its increased abundance across tissues but does not establish that this increase causes the desired benefits.
- Plasma
- The fluid portion of blood. It is one of the locations where S4 reports increased ergothioneine.
- UM-HET3 mice
- The named mouse population studied in S4. The supplied results concern males from this population and do not establish the same effects in other populations or species.
- Preprint
- A research manuscript shared before formal journal peer review. S4 and S9 are identified as preprints in the supplied metadata.
- Brain's protective blood barrier
- The boundary that regulates movement of substances between the blood and brain tissue. S6 includes disruption of this boundary among the routes connecting disturbances in fat tissue to the aging brain.
- Heat shock proteins
- A class of proteins involved in helping other proteins maintain or recover their working form. S7 reports different patterns across members of this class and across tissues, so the term does not describe a single uniformly changing target.
- Long-lived dwarf mice
- The small-bodied, long-lived mice described in S7. Their longevity and tissue patterns are observations in that source, not proof that changing heat shock proteins accounts for their lifespan.
- Deoxyribonucleic acid (DNA) and cell-free DNA
- DNA is the molecule that carries genetic information. Cell-free DNA consists of DNA outside cells, including fragments circulating in blood; S8 does not establish which cells supplied the measured circulating material.
- LINE-1 methylation
- Long interspersed nuclear element-1, abbreviated LINE-1, is a class of repeated DNA sequences. Methylation is the attachment of small chemical marks to DNA, and S8 reports age-related loss of these marks at LINE-1 sequences without establishing that the loss causes aging.
- DNA polymerase alpha
- An enzyme involved in copying DNA. S9 concerns changes involving its gene, but the supplied evidence does not establish it as a shared target that extends lifespan.
- Fruit fly, cell lineage, and intestinal stem cells
- The fruit fly is the Drosophila organism studied in the quoted part of S9. A cell lineage comprises cells related through descent, while intestinal stem cells are cells capable of producing replacement cells in the gut.
- Regeneration
- Restoration of damaged or lost tissue. Better regeneration after a particular injury does not by itself demonstrate slower aging or longer lifespan.
- Gut microbial composition
- The makeup of the community of microorganisms living in the gut. S10 explicitly distinguishes changes in that community from demonstrated gains in healthspan.
Existing mapping and local interventions identify candidates but do not establish a set of shared causal targets with distinguishable dependencies, sustained benefits across several systems, and increased lifespan over a common observation period.
Mapping records where biological features occur, while local interventions change a particular tissue or group of cells. The assumption is that such work has produced possible targets without establishing which ones cause benefits across several systems and extend life. If that assumption holds, the unresolved task is distinguishing shared causes from changes that accompany aging or affect individual organs separately.
The supplied material supports the narrower statement that these sources identify tissue patterns and local effects without establishing the complete causal chain requested. S4 reports a shared chemical change across tissues, S8 reports an age-associated change in brain tissue and blood, and S9 reports regeneration and survival during recovery from injury. None of their supplied excerpts establishes the required shared target, mediator dependence, sustained multisystem function, and lifespan benefit together. This bounded source set does not establish that no other literature does so, and the input does not define its RL-1 and RL-2 evidence levels.S4S8S9
The same question asked without the part nothing read establishes:
- Which tissues, cell populations, or biological compartments have evidence that targeted correction improves several bodily functions and lifespan, with those benefits lost after the proposed mediator is disabled?
- What evidence distinguishes a shared causal target for improvements across body systems from separate effects on individual organs?
- A shared target produces the benefits Under the question's proposed mechanism, correcting the target would act through a common mediator to improve several systems and extend life. Losing those benefits when the mediator is disabled would support dependence on that link, while comparison with competing targets would determine whether the shared target offers the claimed advantage.
- Benefits arise through separate organ effects The change could improve different organs through different routes, so disabling one proposed mediator would not account for the whole pattern of benefits. A single shared target would then be an inadequate explanation, and the observed breadth of benefit would not establish that correcting one link reproduces it.
- Local benefits do not extend lifespan A targeted change could improve a tissue measurement or recovery from injury without producing sustained improvements across several systems. If lifespan does not also increase, that outcome would not meet the question's stated requirement for a shared life-extending target.
The proposed chain starts with a targeted change, passes through a mediator, and reaches the functions of several body systems before affecting lifespan. Similar changes in several tissues could identify a shared link, but those observations alone do not establish that the link produces the benefits. If separate organ effects were mistaken for one shared cause, correcting that supposed cause could fail to reproduce the expected breadth of benefit. Likewise, recovery after injury or a change in a measured biological feature does not by itself establish longer life.
Картирование и локальные вмешательства уровней RL-1 и RL-2 выделяют кандидатов, но экспериментального набора общих мишеней не устанавливают.
Установленный набор причинных мишеней с различимыми зависимостями, устойчивой функциональной пользой и положительным выигрышем продолжительности жизни за общий горизонт наблюдения.
Неизвестно, какие локализованные мишени действительно управляют несколькими системами и какие наблюдаемые эффекты объясняются прямым действием на отдельные органы.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предлагаемый набор состоит только из перивенозных гепатоцитов, содержащих глутаминсинтетазу, с восстановлением её активности в80%клеток этой исходно картированной популяции. Гипотеза утверждает, что после обычных пищевых и двигательных нагрузок именно недостаточное химическое связывание аммиака этой малой популяцией поддерживает общую петлю между печенью, мышцами и мозгом. Коррекция должна уменьшить аммиачные пики, сохранить мышечную силу и когнитивные функции и увеличить оставшуюся продолжительность жизни. Остальные гепатоциты, включая клетки мочевинного цикла, прямой коррекции не требуют. Предполагается, что охвата40%перивенозной популяции недостаточно для связывания остаточного аммиачного потока при сочетании обычных нагрузок, а80%достаточно. Это экспериментальное предположение о минимальном охвате в сравнении с40%и100%.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После коррекции80%перивенозных клеток уменьшаются постпрандиальные аммиачные пики, затем улучшаются восстановление мышечной силы и когнитивные показатели. Эти изменения возникают при сохранении исходных точности синтеза APOB, гормональной пульсации и тимусной презентации антигенов. Охват40%проваливает функциональный критерий при сочетании пищевой и двигательной нагрузок; охват100%эквивалентен80%. Повторное выключение глутаминсинтетазы в скорректированных клетках либо восстановление исходного аммиачного профиля отменяет удалённую пользу. Если коррекция нормализует аммиак, но функции и выживаемость продолжают исходную траекторию, набор отвергается как «серебряная пуля».
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable changes, coverage-dependent comparisons, reversal conditions, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Пространственная маркировка перивенозной популяции, индуцируемое изменение Glul и измерение включения азота в глутамин позволяют проверить локальную реакцию и системный посредник. Селективность вмешательства должна подтверждаться относительно мозга, мышц и других зон печени. При воспроизведении аммиачного профиля необходимо отдельно учитывать сопутствующие изменения глутамина и кислотно-основного состояния.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После коррекции 80% перивенозных клеток уменьшаются постпрандиальные аммиачные пики, затем улучшаются восстановление мышечной силы и когнитивные показатели. Эти изменения возникают при сохранении исходных точности синтеза APOB, гормональной пульсации и тимусной презентации антигенов. Охват 40% проваливает функциональный критерий при сочетании пищевой и двигательной нагрузок; охват 100% эквивалентен 80%. Повторное выключение глутаминсинтетазы в скорректированных клетках либо восстановление исходного аммиачного профиля отменяет удалённую пользу. Если коррекция нормализует аммиак, но функции и выживаемость продолжают исходную траекторию, набор отвергается как «серебряная пуля».
- Rival 01 of 03What would separate them
Errors in liver-made apolipoprotein B may damage blood vessels, muscles and glucose control predicts: В естественно стареющих мышах коррекция указанной половины секреторной продукции улучшает сосудистую реактивность, восстановление мышечной силы и толерантность к глюкозе при сохранении исходных аммиачного профиля, гормональной пульсации и тимусной презентации антигенов. Коррекция четверти продукции не достигает заранее заданных функциональных границ, а увеличение охвата до 75% даёт эквивалентный результат. Возврат выделенной из исходной плазмы фракции липопротеинов с подтверждёнными ошибками в APOB устраняет пользу; контрольная фракция с сопоставимыми липидами и числом частиц её сохраняет. Если эффект объясняется изменением липидного состава либо сохраняется после восстановления исходной нагрузки ошибочного APOB, предложенный посредник отвергается. Продление жизни проверяется отдельно.
- Rival 02 of 03What would separate them
Joint pituitary and adrenal correction may restore hormone pulses and improve multiple functions predicts: Только совместная коррекция двух популяций восстанавливает форму гормональных импульсов и улучшает три функциональные траектории. Коррекция одной популяции либо по 25% клеток каждой не достигает заранее заданной границы; увеличение охвата до 75% эквивалентно 50%. В отдельном опыте замена восстановленного импульсного профиля кортикостерона на исходный возрастной профиль при одинаковой суточной экспозиции устраняет удалённую пользу. Воспроизведение восстановленного профиля у контрольных старых мышей даёт функциональный эффект без коррекции печени или тимуса. Если достаточно одной популяции, гипотеза двухкомпонентного минимума отвергается.
- What would separate them
Loss of thymic self-antigen presentation may drive muscle and metabolic decline predicts: Совместная коррекция двух групп при охвате 80% снижает выход новых Т-лимфоцитов с подтверждённой реактивностью к выбранным собственным антигенам; спустя недели или месяцы улучшаются мышечное восстановление и регуляция глюкозы. Коррекция только мышечной группы даёт преимущественно мышечный эффект, только эндокринной группы даёт преимущественно метаболический эффект, а полный тимусный охват эквивалентен целевому набору. Повторное выключение презентации выбранных антигенов возобновляет появление соответствующих аутореактивных клеток и постепенно устраняет пользу. Немедленное улучшение за часы либо сохранение эффекта при восстановлении исходного выхода аутореактивных клеток противоречит этой гипотезе. Положительный функциональный результат должен сопровождаться отдельным подтверждением выигрыша выживаемости.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
9 quantitative figures appear below and the hypothesis cites no study for any of them. They are the engine's own, and the marks in the text say which.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.